2 citations
,
October 2020 in “Más dermatología” Choose between topical and oral minoxidil for hair growth based on personal tolerance and side effects.
2 citations
,
January 2017 This abstract reviews existing hair loss treatments, highlighting FDA-approved drugs like Minoxidil and Finasteride while noting growing interest in herbal alternatives due to concerns about potential long-term side effects.
2 citations
,
November 2015 in “Journal of Investigative Dermatology Symposium Proceedings” This article discusses the creation of Alopecia Areata Uniform Protocols by the National Alopecia Areata Foundation to standardize clinical trials for alopecia areata treatments and reports no new results.
2 citations
,
September 2007 This article discusses modern hair restoration surgery techniques, the concept of follicular units, and preoperative evaluation considerations, but it reports no new clinical results.
2 citations
,
June 1979 in “JAMA” This article reviews the ineffectiveness and potential dangers of synthetic fiber implantation for pattern baldness and reports no resolution of their ongoing use despite safety concerns.
1 citations
,
July 2016 in “British Journal of Dermatology” Men with a certain type of hair loss often use facial moisturizers, and a specific antibiotic treatment may help another hair condition.
1 citations
,
May 2015 in “Journal of The American Academy of Dermatology” This study concluded that oral minoxidil 5 mg daily was effective in enhancing hair growth in men with androgenetic alopecia, with minor side effects such as hypertrichosis and pedal edema.
1 citations
,
July 2012 in “Springer eBooks” The document concludes that more research is needed to better understand and treat scarring hair loss conditions.
1 citations
,
April 2010 in “Expert Review of Dermatology” This review discusses primary cicatricial alopecias, detailing their classification, pathogenesis, clinical features, histopathologic findings, and treatment, without reporting new experimental results.
1 citations
,
August 2023 in “Journal of Dentomaxillofacial Science” This study found that freeze-dried homologous platelet-rich plasma (FD HPRP) increased osteocalcin levels in cultured osteoblasts, suggesting its potential to support bone regeneration in periodontal treatment.
1 citations
,
November 2019 in “International Journal of Women's Dermatology” Ketoconazole shampoo can cause rare pink hair discoloration.
1 citations
,
February 2022 in “Journal of the American Academy of Dermatology” This review discusses biotin supplementation for dermatological conditions and highlights the lack of strong evidence supporting its efficacy, as well as the potential for laboratory testing interference.
1 citations
,
January 2022 in “Journal of The American Academy of Dermatology” This article discusses various limitations of direct-to-consumer teledermatology platforms, highlighting concerns regarding ethical issues, financial conflicts of interest, and challenges in providing comprehensive patient care compared to traditional in-person consultations.
1 citations
,
July 2021 in “Acta dermatovenerologica Croatica” This case report describes regression of hidradenitis suppurativa lesions in two patients after 16 weeks of adalimumab treatment.
1 citations
,
November 2020 in “Journal of the American Academy of Dermatology” Most sunscreens meet safety standards, but tanning products often don't.
1 citations
,
December 2013 in “Turkderm” This article discusses the increasing use of plant and plant extracts during pregnancy and lactation, highlighting user perceptions of their benefits and safety but does not present new research findings.
1 citations
,
October 1987 in “Drug Information Journal” The article concludes that products can affect the body without being drugs as long as they don't claim to treat or prevent diseases, except for cosmetic sunscreens.
March 2025 in “International Journal of Trichology” This literature review found that Janus kinase inhibitors may help achieve remission in patients with refractory primary neutrophilic cicatricial alopecias, though data is limited to small case series and reports.
May 2024 in “Journal of Education, Health and Sport” This review article highlights the complexity of treating folliculitis decalvans, emphasizing the role of systemic antibiotics like rifampicin and clindamycin as common treatments, while also discussing promising novel therapies, including biological agents, that require further clinical trials to assess their effectiveness and safety.
October 2023 in “Dermatology practical & conceptual” In this case report, folliculitis decalvans with frontal fibrosing alopecia was observed in a patient with a dark phototype, highlighting the phenotypic spectrum of folliculitis decalvans and lichen planopilaris.
September 2023 in “Journal of the American Academy of Dermatology” Topical tofacitinib helped a man with severe scalp condition after other treatments failed.
September 2023 in “Clinical, cosmetic and investigational dermatology” This case series reports successful treatment of refractory folliculitis decalvans using surgical excision with second-intention healing and guarded high-tension suturing, resulting in long-term remission without recurrence over a 10–24 month follow-up period.
January 2019 in “The Egyptian Journal of Hospital Medicine” In this study, researchers evaluated trichoscopic features in 500 Egyptian patients with patchy hair loss and found specific patterns, such as perifollicular scale with 90% sensitivity and 99.5% specificity, which effectively aid in diagnosing primary cicatricial alopecias.
July 2018 in “British Journal of Dermatology” Hair regrowth was seen in 83% of children with alopecia, immune system plays a role in the condition, and various treatments showed effectiveness for hair and nail disorders.
April 2016 in “Journal of The American Academy of Dermatology” The study found that Temporal Triangular Alopecia often starts in early childhood, mainly affects the left side of the scalp, and has no effective treatment except surgery.
April 2016 in “Journal of The American Academy of Dermatology” The study found that Temporal Triangular Alopecia often starts in early childhood, while Folliculitis Decalvans is characterized by tufted hairs and redness around hair follicles.
May 2015 in “Journal of The American Academy of Dermatology” This study found that oral minoxidil 5 mg daily significantly improves hair growth in men with male pattern hair loss, demonstrating safety with minor side effects such as hypertrichosis and pedal edema.
This study reviewed and reclassified 37 cases of primary scarring alopecia using histological methods to achieve more accurate diagnoses within subtypes like lupus erythematosus and lichen planopilaris.
August 2026 in “International Journal of Nanomedicine” This review highlights the potential of exosome-based therapies for androgenetic alopecia by modulating key signaling pathways in hair follicles, suggesting a promising treatment option that requires further research to validate long-term safety and efficacy.
July 2026 in “Journal of the American Academy of Dermatology” Nutraceuticals like Viviscal and Nutrafol can help treat hair loss when used with standard treatments.